Being one of our closest neighbours, Thailand shares many similar healthcare issues we face. Therefore, it's only appropriate that PSS forges closer ties our fellow pharmacists from the Kingdom of Thailand.

Come end of this month, representatives from a UK university will be in Singapore to discuss the possibilities of collaboration with PSS.  The potential areas of collaboration will cover the specialties in the drug regulatory sciences and related industrial field.

Check out the following events and notice. Do take note and mark them on your calendar. Thanks very much.

In the last issue of eBulletin, we reported as a news brief about “The Never Ending IP Tussle with the Generics”. That tussles have indeed not settling; in fact, there is every sign to show that they escalate further!

Here are a few brief news related to healthcare & pharmaceutical scenes for your quick update.

• Hyphens Signed a Regional Deal with American Company Ceragenix to Sell Atopic Dermatitis Drug
• Thai FDA confirms generic heart drug clopidogrel is safe
• Abbott opens US$300m paediatric nutrition & to merge with AMO
• Ranbaxy’s Paonta Sahib Plant in India under FDA Surveillance 

●  EMEA Recommends Suspension of marketing authorisation (MA) of efalizumab (Raptiva^TM) due to potentials for severe side effects.

The following jobs/events are currently available. Kindly apply/register directly based on the information provided. Best of luck!